HK1003227A1 - Material of polysaccharides containing carboxal groups and a process for producing such polysaccharides - Google Patents

Material of polysaccharides containing carboxal groups and a process for producing such polysaccharides

Info

Publication number
HK1003227A1
HK1003227A1 HK98102351A HK98102351A HK1003227A1 HK 1003227 A1 HK1003227 A1 HK 1003227A1 HK 98102351 A HK98102351 A HK 98102351A HK 98102351 A HK98102351 A HK 98102351A HK 1003227 A1 HK1003227 A1 HK 1003227A1
Authority
HK
Hong Kong
Prior art keywords
polysaccharides
pct
carboxal
groups
producing
Prior art date
Application number
HK98102351A
Other languages
English (en)
Inventor
Tomas Malson
Original Assignee
Biomatrix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomatrix Inc filed Critical Biomatrix Inc
Publication of HK1003227A1 publication Critical patent/HK1003227A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/64—Use of materials characterised by their function or physical properties specially adapted to be resorbable inside the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B15/00—Preparation of other cellulose derivatives or modified cellulose, e.g. complexes
    • C08B15/005—Crosslinking of cellulose derivatives
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0021—Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0033—Xanthan, i.e. D-glucose, D-mannose and D-glucuronic acid units, saubstituted with acetate and pyruvate, with a main chain of (beta-1,4)-D-glucose units; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Materials For Medical Uses (AREA)
  • Saccharide Compounds (AREA)
HK98102351A 1986-06-18 1998-03-19 Material of polysaccharides containing carboxal groups and a process for producing such polysaccharides HK1003227A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8602705A SE452469B (sv) 1986-06-18 1986-06-18 Material bestaende av en tverbunden karboxylgrupphaltig polysackarid och forfarande vid framstellning av detsamma
PCT/SE1987/000272 WO1987007898A1 (en) 1986-06-18 1987-06-09 Material of polysaccharides containing carboxyl groups, and a process for producing such polysaccharides

Publications (1)

Publication Number Publication Date
HK1003227A1 true HK1003227A1 (en) 1998-10-16

Family

ID=20364848

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98102351A HK1003227A1 (en) 1986-06-18 1998-03-19 Material of polysaccharides containing carboxal groups and a process for producing such polysaccharides

Country Status (8)

Country Link
US (1) US4963666A (xx)
EP (1) EP0272300B1 (xx)
JP (1) JPH07116242B2 (xx)
AT (1) ATE113609T1 (xx)
DE (1) DE3750719T2 (xx)
HK (1) HK1003227A1 (xx)
SE (1) SE452469B (xx)
WO (1) WO1987007898A1 (xx)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5209626A (en) * 1986-01-22 1993-05-11 Computer Aided Systems, Inc. Organizer system for a rotatable storage structure
US5147861A (en) * 1986-06-30 1992-09-15 Fidia S.P.A. Esters of alginic acid
IT1203814B (it) * 1986-06-30 1989-02-23 Fidia Farmaceutici Esteri dell'acido alginico
US5264422A (en) * 1986-06-30 1993-11-23 Fidia S.P.A. Esters of alginic acid with steroidal alcohols
IT1198449B (it) * 1986-10-13 1988-12-21 F I D I Farmaceutici Italiani Esteri di alcoli polivalenti di acido ialuronico
IT1219587B (it) * 1988-05-13 1990-05-18 Fidia Farmaceutici Polisaccaridi carbossiilici autoreticolati
US5990096A (en) * 1990-09-18 1999-11-23 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
CA2061703C (en) * 1992-02-20 2002-07-02 Rudolf E. Falk Formulations containing hyaluronic acid
US5824658A (en) * 1990-09-18 1998-10-20 Hyal Pharmaceutical Corporation Topical composition containing hyaluronic acid and NSAIDS
US5910489A (en) * 1990-09-18 1999-06-08 Hyal Pharmaceutical Corporation Topical composition containing hyaluronic acid and NSAIDS
US5977088A (en) * 1991-07-03 1999-11-02 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US5792753A (en) * 1991-07-03 1998-08-11 Hyal Pharmaceutical Corporation Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs
US6103704A (en) * 1991-07-03 2000-08-15 Hyal Pharmaceutical Corporation Therapeutic methods using hyaluronic acid
US6218373B1 (en) 1992-02-20 2001-04-17 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US5767106A (en) * 1992-02-21 1998-06-16 Hyal Pharmaceutical Corporation Treatment of disease and conditions associated with macrophage infiltration
US5633001A (en) * 1993-03-19 1997-05-27 Medinvent Composition and a method for tissue augmentation
JP3404557B2 (ja) * 1993-09-30 2003-05-12 グンゼ株式会社 架橋ヒアルロン酸及びこれらの複合材料
US5502042A (en) 1994-07-22 1996-03-26 United States Surgical Corporation Methods and compositions for treating wounds
US5677276A (en) * 1994-12-23 1997-10-14 La Jolla Cancer Research Foundation Immobilization of peptides to hyaluronate
US5827937A (en) * 1995-07-17 1998-10-27 Q Med Ab Polysaccharide gel composition
US6123957A (en) * 1997-07-16 2000-09-26 Jernberg; Gary R. Delivery of agents and method for regeneration of periodontal tissues
AU767859B2 (en) * 1998-12-16 2003-11-27 Nederlandse Organisatie Voor Toegepast- Natuurwetenschappelijk Onderzoek Tno Acidic superabsorbent polysaccharides
GB9902412D0 (en) * 1999-02-03 1999-03-24 Fermentech Med Ltd Process
GB9902652D0 (en) * 1999-02-05 1999-03-31 Fermentech Med Ltd Process
AU3615700A (en) 1999-03-04 2000-09-21 United States Surgical Corporation Scar reduction
ATE531397T1 (de) 1999-05-29 2011-11-15 Tyco Healthcare Bioabsorbierbare mischungen und daraus hergestellte chirurgische artikel
CN100379462C (zh) 1999-11-09 2008-04-09 电气化学工业株式会社 一种包含难溶于水的可溶性纤维素衍生物的组织包被性医疗材料及其制造方法
TW574301B (en) * 2001-05-02 2004-02-01 Ind Tech Res Inst Manufacturing method of epoxide crosslinked polysaccharides matrix
US20040235791A1 (en) * 2002-01-25 2004-11-25 Gruskin Elliott A. Scar reduction
TWI251596B (en) * 2002-12-31 2006-03-21 Ind Tech Res Inst Method for producing a double-crosslinked hyaluronate material
AU2003901834A0 (en) * 2003-04-17 2003-05-01 Clearcoll Pty Ltd Cross-linked polysaccharide compositions
JP2004323454A (ja) * 2003-04-25 2004-11-18 Chisso Corp 薬剤
JP2007500027A (ja) * 2003-07-30 2007-01-11 アンタイス エス．エイ． 生物医学的な使用のための複合マトリックス
DE10343413A1 (de) * 2003-09-19 2005-04-14 Universität Hamburg Vernetzte, langzeitstabile Carboxymethylstärke als Absorptionsmittel für Wasser, deren Verwendung sowie Verfahren zu deren Herstellung
US8124120B2 (en) 2003-12-22 2012-02-28 Anika Therapeutics, Inc. Crosslinked hyaluronic acid compositions for tissue augmentation
GB0329907D0 (en) * 2003-12-23 2004-01-28 Innomed Ltd Compositions
US7651702B2 (en) * 2004-05-20 2010-01-26 Mentor Corporation Crosslinking hyaluronan and chitosanic polymers
US20050281880A1 (en) * 2004-05-20 2005-12-22 Wei Wang Methods for making injectable polymer hydrogels
US20080314835A1 (en) * 2007-01-16 2008-12-25 Regina Valluzzi Chiral separating agents with active support
US8455459B2 (en) 2007-08-02 2013-06-04 Medicis Pharmaceutical Corporation Method of applying an injectable filler
AU2009270900B2 (en) 2008-07-18 2015-03-26 Wake Forest University Health Sciences Apparatus and method for cardiac tissue modulation by topical application of vacuum to minimize cell death and damage
US8450475B2 (en) 2008-08-04 2013-05-28 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
EP2324064B1 (en) 2008-09-02 2017-11-08 Tautona Group LP Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof
SI2742070T1 (sl) 2011-08-10 2021-11-30 Glycores 2000 Srl Proti razgrajevanju odporen, zamreženi hialuronat z nizko molekularno maso
KR101240518B1 (ko) 2012-03-26 2013-03-11 주식회사 제네웰 생체 적합성 고분자를 이용한 이식용 재료
ITMI20120732A1 (it) 2012-05-03 2013-11-04 B S Srl Polisaccaridi reticolati a memoria di forma
CA2916330A1 (en) 2013-06-28 2014-12-31 Galderma S.A. A process for preparing a cross-linked hyaluronic acid product
WO2015044455A1 (en) 2013-09-30 2015-04-02 Galderma S.A. Single-step functionalization and cross-linking of hyaluronic acid
WO2023030435A1 (en) 2021-09-01 2023-03-09 Shanghai Qisheng Biological Preparation Co., Ltd. Cartilage regeneration using injectable, in situ polymerizable collagen compositions containing chondrocytes or stem cells

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE169293C1 (xx) * 1958-03-13 1959-11-10
US3042667A (en) * 1959-03-10 1962-07-03 Pharmacia Ab Process for producing dextran derivatives and products resulting therefrom
CH445129A (fr) * 1964-04-29 1967-10-15 Nestle Sa Procédé pour la préparation de composés d'inclusion à poids moléculaire élevé
US4076930A (en) * 1968-12-13 1978-02-28 James Ellingboe Polysaccharide polyols
US4002173A (en) * 1974-07-23 1977-01-11 International Paper Company Diester crosslinked polyglucan hydrogels and reticulated sponges thereof
JPS55134646A (en) * 1979-04-06 1980-10-20 Kureha Chem Ind Co Ltd Amphoteric ion exchanger
US4370476A (en) * 1979-07-17 1983-01-25 Usher Thomas C Dextran polycarboxylic acids, ferric hydroxide complexes
HU191101B (en) * 1983-02-14 1987-01-28 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt,Hu Process for preparing water-soluble cyclodextrin polymers substituted with ionic groups
SE437270B (sv) * 1983-07-19 1985-02-18 Pharmacia Ab Separationsmaterial av tverbunden agaros och dess framstellning separationsmaterial av tverbunden agaros och dess framstellning
US4716224A (en) * 1984-05-04 1987-12-29 Seikagaku Kogyo Co. Ltd. Crosslinked hyaluronic acid and its use
US4863907A (en) * 1984-06-29 1989-09-05 Seikagaku Kogyo Co., Ltd. Crosslinked glycosaminoglycans and their use
SE456346B (sv) * 1984-07-23 1988-09-26 Pharmacia Ab Gel for att forhindra adhesion mellan kroppsvevnader och sett for dess framstellning
CS249368B1 (en) * 1984-12-29 1987-03-12 Jan Peska Method of pearls detran materials production for gel chromatography
SE8501022L (sv) * 1985-03-01 1986-09-02 Pharmacia Ab Format alster och forfarande for dess framstellning
US4713448A (en) * 1985-03-12 1987-12-15 Biomatrix, Inc. Chemically modified hyaluronic acid preparation and method of recovery thereof from animal tissues
SE453394B (sv) * 1986-07-07 1988-02-01 Pharmacia Ab Forfarande for framstellning av sulfaterade polysackarider genom anvendning av ett reducerande medel for sulfateringsreaktionen

Also Published As

Publication number Publication date
DE3750719D1 (de) 1994-12-08
JPS63503551A (ja) 1988-12-22
EP0272300A1 (en) 1988-06-29
JPH07116242B2 (ja) 1995-12-13
ATE113609T1 (de) 1994-11-15
SE452469B (sv) 1987-11-30
WO1987007898A1 (en) 1987-12-30
EP0272300B1 (en) 1994-11-02
DE3750719T2 (de) 1995-05-11
US4963666A (en) 1990-10-16
SE8602705D0 (sv) 1986-06-18

Similar Documents

Publication Publication Date Title
HK1003227A1 (en) Material of polysaccharides containing carboxal groups and a process for producing such polysaccharides
ATE180508T1 (de) Verfahren zur herstellung von teilchen enthaltend lactambleich mittelaktivator
DE3575710D1 (de) Verfahren und vorrichtung zur herstellung von glasplatten.
DE69003063D1 (de) Verfahren zur herstellung von sulfonylimiden.
DE59102132D1 (de) Verfahren zur Erzeugung von Aktinium-225 und Wismut-213.
DE3871297D1 (de) Zusammensetzung sowie verfahren zum niederschlagen von loetmittel.
DE3587075D1 (de) Kleidungsstruktur und verfahren zur herstellung von kleidungsstuecken.
DE3581512D1 (de) Verfahren zur herstellung von pyrrolo-(3,4-c)-pyrrolen und neue pyrrolo-(3,4-c)-pyrrole.
DE3766029D1 (de) Verfahren und anlage zur herstellung von diamanten.
DE3585417D1 (de) Verfahren und vorrichtung zum herstellen von glasgegenstaenden.
DE3775037D1 (de) Verfahren und vorrichtung zur herstellung von zierschleifen.
ATE82274T1 (de) Morphologisch homogene formen von famotidin und verfahren zu deren herstellung.
AU6124386A (en) Applying powdered materials to filaments
ATE7138T1 (de) Verfahren zur herstellung von 1,5-didesoxy-1,5imino-d-glucitol und dessen n-derivaten.
DE3870633D1 (de) Verfahren zur herstellung von butyrolactonen und von butandiolen.
DE3879614D1 (de) Granulierte zusammensetzung von polysacchariden, verfahren zu deren herstellung und verwendung.
DE3762855D1 (de) Verfahren zur herstellung von hydroxyalkylaminen und hydroxyalkylpiperazinen.
GB2233665B (en) Enzymatically aided soaking process for skins and hides
DE68905327D1 (de) Verfahren zur herstellung von 1,1,1,2-tetrafluorethan.
DE3684922D1 (de) Verfahren zur herstellung von 2-phenylbenzotriazolen und 2-phenylbenzotriazol-n-oxyden.
ATE80594T1 (de) Verfahren zur herstellung von boriden der seltenen erden.
DE3787543D1 (de) Verfahren zur herstellung von 6,13-dihydrochinacridonen und chinacridonen.
DE3763445D1 (de) Verfahren und vorrichtung zum herstellen von reibschluessigen elementen, insbesondere von synchronisierungskoerpern in stufengetrieben von kraftfahrzeugen.
DE3771577D1 (de) Verfahren zur herstellung von diadenosintetraphosphat und derivaten davon.
DE3770224D1 (de) Verfahren zur herstellung von hypofluoriten und bis-hypofluoriten.

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20050609